[go: up one dir, main page]

NO20015058L - Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler - Google Patents

Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler

Info

Publication number
NO20015058L
NO20015058L NO20015058A NO20015058A NO20015058L NO 20015058 L NO20015058 L NO 20015058L NO 20015058 A NO20015058 A NO 20015058A NO 20015058 A NO20015058 A NO 20015058A NO 20015058 L NO20015058 L NO 20015058L
Authority
NO
Norway
Prior art keywords
drugs
preparation
substituted aromatic
aromatic amides
ribose
Prior art date
Application number
NO20015058A
Other languages
English (en)
Other versions
NO20015058D0 (no
NO320703B1 (no
Inventor
Jacques Demassey
Michel Klich
Branislav Musicki
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20015058D0 publication Critical patent/NO20015058D0/no
Publication of NO20015058L publication Critical patent/NO20015058L/no
Publication of NO320703B1 publication Critical patent/NO320703B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20015058A 1999-04-19 2001-10-18 Nye ribose-substituerte aromatiske amider, fremgangsmate for deres fremstilling og farmasoytisk preparat inneholdende disse. NO320703B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
PCT/FR2000/000999 WO2000063222A2 (fr) 1999-04-19 2000-04-18 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
NO20015058D0 NO20015058D0 (no) 2001-10-18
NO20015058L true NO20015058L (no) 2001-12-17
NO320703B1 NO320703B1 (no) 2006-01-16

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015058A NO320703B1 (no) 1999-04-19 2001-10-18 Nye ribose-substituerte aromatiske amider, fremgangsmate for deres fremstilling og farmasoytisk preparat inneholdende disse.

Country Status (24)

Country Link
US (1) US6579902B1 (no)
EP (1) EP1173455A2 (no)
JP (1) JP2002542253A (no)
KR (1) KR100693258B1 (no)
CN (1) CN1213055C (no)
AP (1) AP2001002312A0 (no)
AU (1) AU769514B2 (no)
CA (1) CA2363945A1 (no)
CZ (1) CZ20013708A3 (no)
EA (1) EA004304B1 (no)
FR (1) FR2792320B1 (no)
HK (1) HK1046690B (no)
HU (1) HUP0200778A3 (no)
ID (1) ID30562A (no)
IL (1) IL146018A0 (no)
NO (1) NO320703B1 (no)
NZ (1) NZ515108A (no)
PL (1) PL354192A1 (no)
SK (1) SK14842001A3 (no)
TR (1) TR200103009T2 (no)
UA (1) UA72919C2 (no)
WO (1) WO2000063222A2 (no)
YU (1) YU80301A (no)
ZA (1) ZA200108627B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US7608594B2 (en) * 2004-11-03 2009-10-27 University Of Kansas Novobiocin analogues as anticancer agents
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
EP3794009A1 (en) 2018-05-14 2021-03-24 Reata Pharmaceuticals, Inc. Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
AP2001002312A0 (en) 2001-12-31
WO2000063222A3 (fr) 2001-05-31
NO20015058D0 (no) 2001-10-18
WO2000063222A2 (fr) 2000-10-26
HK1046690B (zh) 2006-03-10
KR100693258B1 (ko) 2007-03-13
EA004304B1 (ru) 2004-02-26
PL354192A1 (en) 2003-12-29
SK14842001A3 (sk) 2003-05-02
HK1046690A1 (en) 2003-01-24
TR200103009T2 (tr) 2002-05-21
AU4125600A (en) 2000-11-02
ZA200108627B (en) 2002-10-21
CA2363945A1 (fr) 2000-10-26
NZ515108A (en) 2004-01-30
CN1213055C (zh) 2005-08-03
ID30562A (id) 2001-12-20
FR2792320B1 (fr) 2003-05-09
FR2792320A1 (fr) 2000-10-20
CN1357001A (zh) 2002-07-03
EP1173455A2 (fr) 2002-01-23
HUP0200778A3 (en) 2003-03-28
AU769514B2 (en) 2004-01-29
CZ20013708A3 (cs) 2002-04-17
YU80301A (sh) 2005-07-19
HUP0200778A2 (hu) 2002-07-29
NO320703B1 (no) 2006-01-16
UA72919C2 (uk) 2005-05-16
EA200101100A1 (ru) 2002-04-25
KR20020008155A (ko) 2002-01-29
IL146018A0 (en) 2002-07-25
US6579902B1 (en) 2003-06-17
JP2002542253A (ja) 2002-12-10

Similar Documents

Publication Publication Date Title
DK1045856T3 (da) Nye aromatiske amider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
NO20025879D0 (no) Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
NO20040680D0 (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
NO20025133L (no) Nye, lengevirkende betamimetika, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter
NO20006029L (no) Pyrazolinderivater, deres fremstilling og anvendelse som legemidler
NO20030302L (no) Nye heteroarylderivater og deres anvendelse som medikamenter
NO20030298D0 (no) Nye heteroarylderivater og deres anvendelse som farmasöytiske midler
NO20011503L (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO20005146L (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1004592T3 (da) Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter
NO20023146L (no) Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
NO20030382D0 (no) Nye indolderivater og deres anvendelse som medikamenter
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
DK1200444T3 (da) Nye xanthon-forbindelser, deres fremstilling og anvendelse som lægemiddel
DK0906326T3 (da) Nye aromatiske derivater substitueret med en ribose, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
DK1157014T3 (da) Polycykliske 2-amino-dihydrothiazolsystemer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO20023188D0 (no) Nye heteroarylderivater, deres fremstilling og anvendelse
NO20014149D0 (no) Nye dipeptidforbindelser og deres anvendelse som medisiner
DK0946580T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler